"Rise of JN.1: The New COVID Variant's Spread and Unique Symptoms"
TL;DR
Israel has reported approximately 200 cases of a new COVID-19 sub-variant named JN.1, which is contributing to a slight increase in morbidity rates. The CDC has warned of its rapid spread and potential impact on hospitalizations, although early data indicates current vaccines may be less effective against it. The WHO expert group believes the changes in JN.1 do not necessitate a new vaccine formula at this time.
- Hundreds of Israelis contract new COVID sub-variant JN.1 The Jerusalem Post
- COVID-19 variant JN.1 symptoms: Is 'Pirola' different from other Omicron spawn? Fortune
- New COVID strain quickly becomes most dominant in U.S. Axios
- New JN. 1 Covid variant gains ground in US ahead of holiday season Financial Times
- Covid JN.1 variant: Common symptoms and key differences from other Omicron variants Hindustan Times
Want the full story? Read the original reporting
Read on The Jerusalem Post